Exploring the antiviral activity of Adhatoda beddomei bioactive compounds in interaction with coronavirus spike protein 3(1) (2024) 1-6
Safdar Ali, Omaisa Ejaz Asad, Zohya Punjwani, Saiqa Aslam, Isha Fathima, Omaisa Ejaz Asad, Open Access
Exploring the antiviral activity of Adhatoda beddomei bioactive compounds in interaction with coronavirus spike protein, 1(1), 1-6 Retrieved from https://archmedrep. com/index.php/amr/article/view/3 This study explores the pharmacokinetic properties, drug-likeness, and molecular docking potential of bioactive compounds from Adhatoda beddomei as potential inhibitors of the coronavirus spike protein. Using SwissADME, we evaluated the pharmacokinetic profiles and drug-likeness of compounds such as Naringenin, Epicatechin, Morin, Quercetin, and Epigallocatechin. The results indicate high gastrointestinal absorption and favorable drug-likeness profiles, though none of the compounds are capable of crossing the blood-brain barrier. Molecular docking studies were conducted to assess the binding affinity of these compounds with the coronavirus spike protein. The spike protein structure was obtained from the RCSB Protein Data Bank and prepared using PyMOL, while the ligand structures were optimized in Discovery Studio. Docking simulations, performed using AutoDock Vina, revealed that Naringenin, Morin, and Quercetin exhibit strong binding affinities, with Naringenin demonstrating the highest binding affinity (-6.8 kcal/ mol). These findings suggest that bioactive compounds from Adhatoda beddomei possess significant potential as antiviral agents. The integration of pharmacokinetic assessments and molecular docking provides a comprehensive framework for advancing these compounds as therapeutic candidates for treating coronavirus infections. Further studies are recommended to elucidate the mechanisms of action, optimize pharmacokinetic properties, and validate the efficacy in preclinical and clinical settings.
Competing Interests The authors declare that they have no conflict of interest
Author contribution Conceptualization, Data curation, Investigation: O.E.A, Z.P. Formal analysis:S.A. Writing-review and editing: S.A. All authors have read and agreed to the published version of the manuscript
References
Bakchi, Krishna, Sreecharan, Ganesh, Niharika et al., An overview on applications of SwissADME web tool in the design and development of anticancer, antitubercular and antimicrobial agents: A medicinal chemist's perspective, J. Mol. Struct,
doi:10.1016/j.molstruc.2022.132712Biharee, Bhartiya, Dubey, Yadav, Sharma et al., Ethnobotanical notes and pharmacological overview of traditional plant: Adhatoda vasica, Dermatological Rev,
doi:10.1002/der2.170Chawla, None
Daina, Michielin, Zoete, SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep,
doi:10.1038/srep42717Furtado, Björnmalm, Ayton, Bush, Kempe et al., Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases, Adv. Mater,
doi:10.1002/adma.201801362Gheware, Dholakia, Kannan, Panda, Rani et al., Adhatoda Vasica attenuates inflammatory and hypoxic responses in preclinical mouse models: potential for repurposing in COVID-19-like conditions, Respir. Res,
doi:10.1186/s12931-021-01698-9Huang, Song, Huang, Sun, Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19, J. Clin. Med,
doi:10.3390/jcm9041131Joshi, Panda, Jouneghani, Liu, Parajuli et al., Antibacterial, Antifungal, Antiviral, and Anthelmintic Activities of Medicinal Plants of Nepal Selected Based on Ethnobotanical Evidence. Evidence-Based Complement, Altern. Med,
doi:10.1155/2020/1043471Khursheed, Devender, Ansari, Phytochemical and Pharmacological Investigations on Adhatoda zeylanica (Medic.): A Review, Pharmacogn. J,
doi:10.1016/S0975-3575(10)80041-0Krishna, Vani, Prasad, Samatha, Bindu et al., Insilico molecular docking analysis of prodigiosin and cycloprodigiosin as COX-2 inhibitors, Springerplus,
doi:10.1186/2193-1801-2-172Marasini, Baral, Aryal, Ghimire, Neupane et al., Evaluation of Antibacterial Activity of Some Traditionally Used Medicinal Plants against Human Pathogenic Bacteria, Biomed Res. Int,
doi:10.1155/2015/265425Pa, Mathew, Antimicrobial activity of leaf extracts of Justicia adhatoda L. in comparison with vasicine, Asian Pac. J. Trop. Biomed,
doi:10.1016/S2221-1691(12)60452-3Papageorgiou, Mohsin, The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies, Cells,
doi:10.3390/cells9112343Singh, Kumar, Reddy, Rameshkumar, Kumar, Screening of tricyclic quinazoline alkaloids in the alkaloidal fraction of Adhatoda beddomei and Adhatoda vasica leaves by high-performance liquid chromatography/ electrospray ionization quadrupole time-of-flight tandem mass spectrometry, Rapid Commun. Mass Spectrom,
doi:10.1002/rcm.7126Sympli, Estimation of drug-likeness properties of GC-MS separated bioactive compounds in rare medicinal Pleione maculata using molecular docking technique and SwissADME in silico tools, Netw. Model. Anal. Heal. Informatics Bioinforma,
doi:10.1007/s13721-020-00276-1Tao, Du, Li, Zeng, Tan et al., Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19, Drug Dev. Ind. Pharm,
doi:10.1080/03639045.2020.1788070Terstappen, Meyer, Bell, Zhang, Strategies for delivering therapeutics across the blood-brain barrier, Nat. Rev. Drug Discov,
doi:10.1038/s41573-021-00139-y
